Published in Int J Clin Oncol on February 25, 2007
Stochastic rank correlation: a robust merit function for 2D/3D registration of image data obtained at different energies. Med Phys (2009) 1.12
Complications associated with the percutaneous insertion of fiducial markers in the thorax. Cardiovasc Intervent Radiol (2010) 0.91
Motion management in gastrointestinal cancers. J Gastrointest Oncol (2014) 0.83
Assessing four-dimensional radiotherapy planning and respiratory motion-induced dose difference based on biologically effective uniform dose. Technol Cancer Res Treat (2009) 0.77
Helical tomotherapy with concurrent capecitabine for the treatment of inoperable pancreatic cancer. Radiat Oncol (2010) 0.76
Adaptive management of liver cancer radiotherapy. Semin Radiat Oncol (2010) 0.76
Design and testing of a simulation framework for dosimetric motion studies integrating an anthropomorphic computational phantom into four-dimensional Monte Carlo. Technol Cancer Res Treat (2008) 0.76
Short-term outcomes of CyberKnife therapy for advanced high-risk tumors: A report of 160 cases. Exp Ther Med (2012) 0.75
Precise and real-time measurement of 3D tumor motion in lung due to breathing and heartbeat, measured during radiotherapy. Int J Radiat Oncol Biol Phys (2002) 4.24
Physical aspects of a real-time tumor-tracking system for gated radiotherapy. Int J Radiat Oncol Biol Phys (2000) 2.24
Feasibility of insertion/implantation of 2.0-mm-diameter gold internal fiducial markers for precise setup and real-time tumor tracking in radiotherapy. Int J Radiat Oncol Biol Phys (2003) 2.00
Four-dimensional treatment planning and fluoroscopic real-time tumor tracking radiotherapy for moving tumor. Int J Radiat Oncol Biol Phys (2000) 1.68
Prediction of respiratory tumour motion for real-time image-guided radiotherapy. Phys Med Biol (2004) 1.66
Three-dimensional intrafractional movement of prostate measured during real-time tumor-tracking radiotherapy in supine and prone treatment positions. Int J Radiat Oncol Biol Phys (2002) 1.63
Residual motion of lung tumours in gated radiotherapy with external respiratory surrogates. Phys Med Biol (2005) 1.54
Calculation of rotational setup error using the real-time tracking radiation therapy (RTRT) system and its application to the treatment of spinal schwannoma. Int J Radiat Oncol Biol Phys (2002) 1.52
Real-time tumour-tracking radiotherapy. Lancet (1999) 1.42
Intrafractional tumor motion: lung and liver. Semin Radiat Oncol (2004) 1.37
Focal, high dose, and fractionated modified stereotactic radiation therapy for lung carcinoma patients: a preliminary experience. Cancer (1998) 1.37
Speed and amplitude of lung tumor motion precisely detected in four-dimensional setup and in real-time tumor-tracking radiotherapy. Int J Radiat Oncol Biol Phys (2006) 1.28
Detection of lung tumor movement in real-time tumor-tracking radiotherapy. Int J Radiat Oncol Biol Phys (2001) 1.22
Use of an implanted marker and real-time tracking of the marker for the positioning of prostate and bladder cancers. Int J Radiat Oncol Biol Phys (2000) 1.18
Tumor location, cirrhosis, and surgical history contribute to tumor movement in the liver, as measured during stereotactic irradiation using a real-time tumor-tracking radiotherapy system. Int J Radiat Oncol Biol Phys (2003) 1.13
Technical aspects of image-guided respiration-gated radiation therapy. Med Dosim (2006) 1.12
Real-time monitoring of a digestive tract marker to reduce adverse effects of moving organs at risk (OAR) in radiotherapy for thoracic and abdominal tumors. Int J Radiat Oncol Biol Phys (2005) 1.10
Impact of respiratory movement on the computed tomographic images of small lung tumors in three-dimensional (3D) radiotherapy. Int J Radiat Oncol Biol Phys (2000) 1.08
Registration accuracy and possible migration of internal fiducial gold marker implanted in prostate and liver treated with real-time tumor-tracking radiation therapy (RTRT). Radiother Oncol (2002) 1.08
Insertion and fixation of fiducial markers for setup and tracking of lung tumors in radiotherapy. Int J Radiat Oncol Biol Phys (2005) 1.08
Three-dimensional movement of a liver tumor detected by high-speed magnetic resonance imaging. Radiother Oncol (1999) 0.99
Real-time tumor-tracking radiation therapy for lung carcinoma by the aid of insertion of a gold marker using bronchofiberscopy. Cancer (2002) 0.98
High-speed magnetic resonance imaging for four-dimensional treatment planning of conformal radiotherapy of moving body tumors. Int J Radiat Oncol Biol Phys (2000) 0.92
Application of real-time tumor-tracking and gated radiotherapy system for unresectable pancreatic cancer. Yonsei Med J (2004) 0.90
Three-dimensional conformal setup (3D-CSU) of patients using the coordinate system provided by three internal fiducial markers and two orthogonal diagnostic X-ray systems in the treatment room. Int J Radiat Oncol Biol Phys (2004) 0.81
High dose three-dimensional conformal boost (3DCB) using an orthogonal diagnostic X-ray set-up for patients with gynecological malignancy: a new application of real-time tumor-tracking system. Radiother Oncol (2004) 0.80
Uncertainty in treatment of head-and-neck tumors by use of intraoral mouthpiece and embedded fiducials. Int J Radiat Oncol Biol Phys (2006) 0.77
Precise and real-time measurement of 3D tumor motion in lung due to breathing and heartbeat, measured during radiotherapy. Int J Radiat Oncol Biol Phys (2002) 4.24
Dosimetric comparison between intensity-modulated radiotherapy and standard wedged tangential technique for whole-breast radiotherapy in Asian women with relatively small breast volumes. Radiol Phys Technol (2013) 2.02
Feasibility of insertion/implantation of 2.0-mm-diameter gold internal fiducial markers for precise setup and real-time tumor tracking in radiotherapy. Int J Radiat Oncol Biol Phys (2003) 2.00
Prediction of respiratory tumour motion for real-time image-guided radiotherapy. Phys Med Biol (2004) 1.66
Tolerance of organs at risk in small-volume, hypofractionated, image-guided radiotherapy for primary and metastatic lung cancers. Int J Radiat Oncol Biol Phys (2003) 1.63
Three-dimensional intrafractional movement of prostate measured during real-time tumor-tracking radiotherapy in supine and prone treatment positions. Int J Radiat Oncol Biol Phys (2002) 1.63
Characteristics of patients who developed radiation pneumonitis requiring steroid therapy after stereotactic irradiation for lung tumors. Cancer J (2006) 1.52
Intrafractional tumor motion: lung and liver. Semin Radiat Oncol (2004) 1.37
Radiation pneumonitis in patients treated for malignant pulmonary lesions with hypofractionated radiation therapy. Radiother Oncol (2009) 1.29
Speed and amplitude of lung tumor motion precisely detected in four-dimensional setup and in real-time tumor-tracking radiotherapy. Int J Radiat Oncol Biol Phys (2006) 1.28
Hypofractionated stereotactic radiotherapy alone without whole-brain irradiation for patients with solitary and oligo brain metastasis using noninvasive fixation of the skull. Int J Radiat Oncol Biol Phys (2003) 1.24
Clinical outcomes of stereotactic brain and/or body radiotherapy for patients with oligometastatic lesions. Jpn J Clin Oncol (2010) 1.18
Tumor location, cirrhosis, and surgical history contribute to tumor movement in the liver, as measured during stereotactic irradiation using a real-time tumor-tracking radiotherapy system. Int J Radiat Oncol Biol Phys (2003) 1.13
Ruptured distal anterior inferior cerebellar artery aneurysm following stereotactic irradiation for vestibular schwannoma: case report. Neurol Med Chir (Tokyo) (2009) 1.12
Real-time monitoring of a digestive tract marker to reduce adverse effects of moving organs at risk (OAR) in radiotherapy for thoracic and abdominal tumors. Int J Radiat Oncol Biol Phys (2005) 1.10
Stereotactic radiotherapy for intracranial nonacoustic schwannomas including facial nerve schwannoma. Int J Radiat Oncol Biol Phys (2009) 1.09
Registration accuracy and possible migration of internal fiducial gold marker implanted in prostate and liver treated with real-time tumor-tracking radiation therapy (RTRT). Radiother Oncol (2002) 1.08
Insertion and fixation of fiducial markers for setup and tracking of lung tumors in radiotherapy. Int J Radiat Oncol Biol Phys (2005) 1.08
Real-time 4-D radiotherapy for lung cancer. Cancer Sci (2011) 1.07
Exophytic giant cavernous hemangioma of the liver with growing tendency. Radiat Med (2005) 1.06
Concomitant weekly cisplatin and radiotherapy for head and neck cancer. Jpn J Clin Oncol (2011) 1.04
Correlation of gross tumor volume excursion with potential benefits of respiratory gating. Int J Radiat Oncol Biol Phys (2004) 1.04
Evaluation of a contour-alignment technique for CT-guided prostate radiotherapy: an intra- and interobserver study. Int J Radiat Oncol Biol Phys (2004) 1.03
Three-dimensional intrafractional motion of breast during tangential breast irradiation monitored with high-sampling frequency using a real-time tumor-tracking radiotherapy system. Int J Radiat Oncol Biol Phys (2007) 1.02
Stereotactic body radiotherapy using gated radiotherapy with real-time tumor-tracking for stage I non-small cell lung cancer. Radiat Oncol (2013) 0.99
Real-time tumor-tracking radiation therapy for lung carcinoma by the aid of insertion of a gold marker using bronchofiberscopy. Cancer (2002) 0.98
Clinical outcomes of stereotactic body radiotherapy for small lung lesions clinically diagnosed as primary lung cancer on radiologic examination. Int J Radiat Oncol Biol Phys (2009) 0.95
Real-time tumor-tracking radiotherapy for adrenal tumors. Radiother Oncol (2008) 0.92
Co-overexpression of GEP100 and AMAP1 proteins correlates with rapid local recurrence after breast conservative therapy. PLoS One (2013) 0.91
Application of real-time tumor-tracking and gated radiotherapy system for unresectable pancreatic cancer. Yonsei Med J (2004) 0.90
Clinical outcomes of stereotactic body radiotherapy for patients with lung tumors in the state of oligo-recurrence. Pulm Med (2012) 0.90
Efficacy of therapy for advanced hepatocellular carcinoma: intra-arterial 5-fluorouracil and subcutaneous interferon with image-guided radiation. J Gastroenterol Hepatol (2011) 0.89
Management of vestibular schwannoma by fractionated stereotactic radiotherapy and associated cerebrospinal fluid malabsorption. J Neurosurg (2003) 0.89
Radiation pneumonitis after hypofractionated radiotherapy: evaluation of the LQ(L) model and different dose parameters. Int J Radiat Oncol Biol Phys (2010) 0.89
Dose-volume analysis for respiratory toxicity in intrathoracic esophageal cancer patients treated with definitive chemoradiotherapy using extended fields. J Radiat Res (2013) 0.88
Tracking errors in a prototype real-time tumour tracking system. Phys Med Biol (2004) 0.88
Intercepting radiotherapy using a real-time tumor-tracking radiotherapy system for highly selected patients with hepatocellular carcinoma unresectable with other modalities. Int J Radiat Oncol Biol Phys (2007) 0.87
Superselective arterial cisplatin infusion with concomitant radiation therapy for base of tongue cancer. Oral Oncol (2011) 0.87
Use of implanted markers and interportal adjustment with real-time tracking radiotherapy system to reduce intrafraction prostate motion. Int J Radiat Oncol Biol Phys (2011) 0.86
MR imaging of primary malignant lymphoma of the pancreas. Radiat Med (2005) 0.86
What is the appropriate size criterion for proton radiotherapy for hepatocellular carcinoma? A dosimetric comparison of spot-scanning proton therapy versus intensity-modulated radiation therapy. Radiat Oncol (2013) 0.85
A mathematical study to select fractionation regimen based on physical dose distribution and the linear-quadratic model. Int J Radiat Oncol Biol Phys (2012) 0.84
Reduction of bed rest time after transfemoral noncardiac angiography from 4 hours to 2 hours: a randomized trial and a one-arm study. J Vasc Interv Radiol (2009) 0.84
Evaluation of the effectiveness of the stereotactic body frame in reducing respiratory intrafractional organ motion using the real-time tumor-tracking radiotherapy system. Int J Radiat Oncol Biol Phys (2010) 0.84
[18F]fluoromisonidazole and a new PET system with semiconductor detectors and a depth of interaction system for intensity modulated radiation therapy for nasopharyngeal cancer. Int J Radiat Oncol Biol Phys (2012) 0.84
Longitudinal comparison of quality of life after real-time tumor-tracking intensity-modulated radiation therapy and radical prostatectomy in patients with localized prostate cancer. J Radiat Res (2013) 0.83
Focal fractionated radiotherapy for intramedullary spinal arteriovenous malformations: 10-year experience. J Neurosurg (2003) 0.82
Severe tumor budding is a risk factor for lateral lymph node metastasis in early rectal cancers. J Surg Oncol (2010) 0.82
Biological effect of dose distortion by fiducial markers in spot-scanning proton therapy with a limited number of fields: a simulation study. Med Phys (2012) 0.82
Three-dimensional conformal setup (3D-CSU) of patients using the coordinate system provided by three internal fiducial markers and two orthogonal diagnostic X-ray systems in the treatment room. Int J Radiat Oncol Biol Phys (2004) 0.81
Comparison of acute toxicities associated with cetuximab-based bioradiotherapy and platinum-based chemoradiotherapy for head and neck squamous cell carcinomas: A single-institution retrospective study in Japan. Acta Otolaryngol (2015) 0.81
Accurate analysis of the change in volume, location, and shape of metastatic cervical lymph nodes during radiotherapy. Int J Radiat Oncol Biol Phys (2011) 0.81
Integration of a real-time tumor monitoring system into gated proton spot-scanning beam therapy: an initial phantom study using patient tumor trajectory data. Med Phys (2013) 0.81
Prospective phase II study of image-guided local boost using a real-time tumor-tracking radiotherapy (RTRT) system for locally advanced bladder cancer. Jpn J Clin Oncol (2013) 0.81
Optimization of fluoroscopy parameters using pattern matching prediction in the real-time tumor-tracking radiotherapy system. Phys Med Biol (2011) 0.79
Phase I study of concurrent real-time tumor-tracking thoracic radiation therapy with paclitaxel and carboplatin in locally advanced non-small cell lung cancer. Lung Cancer (2011) 0.79
Total number of lymph node metastases is a more significant risk factor for poor prognosis than positive lateral lymph node metastasis. Surg Today (2014) 0.78
High dose three-dimensional conformal boost using the real-time tumor tracking radiotherapy system in cervical cancer patients unable to receive intracavitary brachytherapy. Yonsei Med J (2009) 0.78
Hypofractionated radiotherapy boost for dose escalation as a treatment option for high-grade spinal cord astrocytic tumor. J Neurooncol (2005) 0.78
Feasibility and efficacy of induction docetaxel, cisplatin, and 5-fluorouracil chemotherapy combined with concurrent weekly cisplatin chemoradiotherapy for locally advanced head and neck squamous cell carcinoma. Int J Clin Oncol (2014) 0.78
Value of fluorodeoxyglucose positron emission tomography before radiotherapy for head and neck cancer: does the standardized uptake value predict treatment outcome? Jpn J Radiol (2009) 0.78
Histopathologic consideration of fiducial gold markers inserted for real-time tumor-tracking radiotherapy against lung cancer. Int J Radiat Oncol Biol Phys (2007) 0.78
Uncertainty in treatment of head-and-neck tumors by use of intraoral mouthpiece and embedded fiducials. Int J Radiat Oncol Biol Phys (2006) 0.77
The incidence of late neck recurrence in N0 maxillary sinus squamous cell carcinomas after superselective intra-arterial chemoradiotherapy without prophylactic neck irradiation. Eur Arch Otorhinolaryngol (2013) 0.77
Early results of urethral dose reduction and small safety margin in intensity-modulated radiation therapy (IMRT) for localized prostate cancer using a real-time tumor-tracking radiotherapy (RTRT) system. Radiat Oncol (2014) 0.77
Combined modality therapy for laryngeal cancer with superselective intra-arterial cisplatin infusion and concomitant radiotherapy. Int J Clin Oncol (2011) 0.77
Long-term results of ethmoid squamous cell or undifferentiated carcinoma treated with radiotherapy with or without surgery. Cancer J (2005) 0.77
Evaluation of inter-observer variability of bladder boundary delineation on cone-beam CT. Radiat Oncol (2013) 0.77
A new brain positron emission tomography scanner with semiconductor detectors for target volume delineation and radiotherapy treatment planning in patients with nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys (2012) 0.76
Symptomatic outcomes in relation to tumor expansion after fractionated stereotactic radiation therapy for vestibular schwannomas: single-institutional long-term experience. Int J Radiat Oncol Biol Phys (2012) 0.76
Positive peritoneal washing cytology is a potential risk factor for the recurrence of curatively resected colorectal cancer. Surg Today (2013) 0.76
Relationship between diseased lung tissues on computed tomography and motion of fiducial marker near lung cancer. Int J Radiat Oncol Biol Phys (2010) 0.76
Comparison of cisplatin and 5-fluorouracil chemotherapy protocols combined with concurrent radiotherapy for esophageal cancer. Jpn J Radiol (2009) 0.75
Three-dimensional conformal radiotherapy for astrocytic tumors involving the eloquent area in children and young adults. J Neurooncol (2002) 0.75
Multiple granulomatous lung lesions in a patient with Epstein-Barr-virus-induced mononucleosis and new-onset systemic lupus erythematosus: a case report. J Med Case Rep (2012) 0.75